At a glance
ClinicalIndex Comparison RecordPhase 1Completed· 52 enrolled
Drug / intervention
Esomeprazole Capsule +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Phase 1, Randomized, Open-label, 2-way Cross-over Study to Evaluate the Bioequivalence Between a Single Oral Dose of Esomeprazole 40 mg Capsules and Esomeprazole 40 mg Tablets in Healthy Subjects
In Brief
A Phase 1 clinical trial evaluating Esomeprazole Capsule and Esomeprazole Tablet for Healthy Participants. Completed, enrolled 52 participants across 1 site.
Detailed Summary
The purpose of this study is to determine the bioequivalence of esomeprazole 40 milligram (mg) tablets and capsules.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHealthy Participants
CountriesUnited States
Collaborators--
Timeline
Phase 1CompletedFinished
2017201820192020202120222023202420252026
First PostedMar 2017
Enrollment StartMar 2017
Primary CompletionMay 2017
TodayJul 2026
First PostedMar 20, 2017
Enrollment StartMar 27, 2017
Primary CompletionMay 13, 2017
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 9.3 years ago
Interventions
Esomeprazole Capsuledrug
Esomeprazole Capsule
Esomeprazole Tabletdrug
Esomeprazole Tablet